Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 2
2016 3
2017 1
2018 4
2019 6
2020 8
2021 14
2022 4
2023 4
2024 5

Text availability

Article attribute

Article type

Publication date

Search Results

44 results

Results by year

Filters applied: . Clear all
Page 1
Budesonide as first-line treatment in patients with autoimmune hepatitis seems inferior to standard predniso(lo)ne administration.
Díaz-González Á, Hernández-Guerra M, Pérez-Medrano I, Sapena V, Riveiro-Barciela M, Barreira-Díaz A, Gómez E, Morillas RM, Del Barrio M, Escudé L, Mateos B, Horta D, Gómez J, Conde I, Ferre-Aracil C, El Hajra I, Arencibía A, Zamora J, Fernández A, Salcedo M, Molina E, Soria A, Estévez P, López C, Álvarez-Navascúes C, García-Retortillo M, Crespo J, Londoño MC; ColHai Registry. Díaz-González Á, et al. Hepatology. 2023 Apr 1;77(4):1095-1105. doi: 10.1097/HEP.0000000000000018. Epub 2023 Jan 3. Hepatology. 2023. PMID: 36626622 Free article.
Controversies in the management of hepatocellular carcinoma.
Forner A, Da Fonseca LG, Díaz-González Á, Sanduzzi-Zamparelli M, Reig M, Bruix J. Forner A, et al. Among authors: diaz gonzalez a. JHEP Rep. 2019 Mar 18;1(1):17-29. doi: 10.1016/j.jhepr.2019.02.003. eCollection 2019 May. JHEP Rep. 2019. PMID: 32039350 Free PMC article. Review.
Surveillance for hepatocellular carcinoma.
Díaz-González Á, Forner A. Díaz-González Á, et al. Best Pract Res Clin Gastroenterol. 2016 Dec;30(6):1001-1010. doi: 10.1016/j.bpg.2016.10.006. Epub 2016 Oct 21. Best Pract Res Clin Gastroenterol. 2016. PMID: 27938779 Review.
New Systemic Treatments in Advanced Hepatocellular Carcinoma.
Sanduzzi-Zamparelli M, Díaz-Gonzalez Á, Reig M. Sanduzzi-Zamparelli M, et al. Among authors: diaz gonzalez a. Liver Transpl. 2019 Feb;25(2):311-322. doi: 10.1002/lt.25354. Liver Transpl. 2019. PMID: 30317696 Review.
Treatment of Hepatocellular Carcinoma.
Díaz-González Á, Reig M, Bruix J. Díaz-González Á, et al. Dig Dis. 2016;34(5):597-602. doi: 10.1159/000445275. Epub 2016 Jun 22. Dig Dis. 2016. PMID: 27332893 Review.
Budesonide in the first line treatment of patients with autoimmune hepatitis.
Olivas I, Cobreros M, Londoño MC, Díaz-González Á. Olivas I, et al. Among authors: diaz gonzalez a. Gastroenterol Hepatol. 2022 Aug-Sep;45(7):561-570. doi: 10.1016/j.gastrohep.2021.11.012. Epub 2021 Dec 16. Gastroenterol Hepatol. 2022. PMID: 34923033 Review. English, Spanish.
New challenges in clinical research on hepatocellular carcinoma.
Díaz-González Á, Forner A, Rodríguez de Lope C, Varela M. Díaz-González Á, et al. Rev Esp Enferm Dig. 2016 Aug;108(8):485-93. doi: 10.17235/reed.2015.4012/2015. Rev Esp Enferm Dig. 2016. PMID: 26653993 Free article. Review.
Prognosis prediction and staging.
Forner A, Díaz-González A, Liccioni A, Vilana R. Forner A, et al. Among authors: diaz gonzalez a. Best Pract Res Clin Gastroenterol. 2014 Oct;28(5):855-65. doi: 10.1016/j.bpg.2014.08.002. Epub 2014 Aug 23. Best Pract Res Clin Gastroenterol. 2014. PMID: 25260313 Review.
Immune Checkpoint Inhibitors: The Emerging Cornerstone in Cholangiocarcinoma Therapy?
Gutiérrez-Larrañaga M, González-López E, Roa-Bautista A, Rodrigues PM, Díaz-González Á, Banales JM, López-Hoyos M, Santos-Laso A, Crespo J. Gutiérrez-Larrañaga M, et al. Among authors: diaz gonzalez a. Liver Cancer. 2021 Sep 21;10(6):545-560. doi: 10.1159/000518104. eCollection 2021 Nov. Liver Cancer. 2021. PMID: 34950178 Free PMC article. Review.
44 results